GlaxoSmithKline News

6-K: Transaction Notification

May 14 10:59 ET

6-K: Block Listing Six Monthly Return

May 13 10:54 ET

6-K: Gsk Results of 24th Annual General Meeting

May 8 13:48 ET

6-K: Gsk Board Committee Change

May 8 13:03 ET

6-K: Transaction Notification

May 3 10:46 ET

6-K: Total Voting Rights and Capital

May 1 11:19 ET

6-K: Us Fda Accepts for Priority Review Gsk's Application for an Expanded Indication of Jemperli Plus Chemotherapy to Include All Adult Patients with Primary Advanced or Recurrent Endometrial Cancer

Apr 24 06:48 ET

6-K: Transaction Notification

Apr 19 10:59 ET

6-K: Transaction Notification

Apr 17 10:54 ET

6-K: New Long-Term Data Show Shingrix Continues to Provide High Protection Against Shingles in Adults Aged 50 and over for More Than a Decade

Apr 17 06:14 ET

6-K: Gsk Today Announced Positive Results from the Pivotal Eagle-1 Phase Iii Trial for Gepotidacin

Apr 17 06:09 ET

6-K: The Following Amendments Have Been Made in Accordance with the “director/Pdmr Shareholdings” Announcement Issued by Rns No 6709k

Apr 16 09:55 ET

6-K: GSK's 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA

Apr 16 06:24 ET

GlaxoSmithKline | 6-K: Transaction Notification

Apr 15 11:29 ET

GlaxoSmithKline | 6-K/A: Total Voting Rights and Capital

Apr 4 07:50 ET

GlaxoSmithKline | 6-K: Total Voting Rights and Capital

Apr 2 13:20 ET

GlaxoSmithKline | 6-K: Transaction Notification

Mar 26 07:49 ET

GlaxoSmithKline | 6-K: GlaxoSmithKline releases notice of 2024 Annual General Meeting of Shareholders

Mar 25 09:43 ET

GlaxoSmithKline | 6-K: Transfer of Treasury Shares

Mar 22 12:52 ET

GlaxoSmithKline | 6-K: Transaction Notification

Mar 22 12:22 ET